Therefore, the reduction of circulating BMP-9 in subjects with MetS might be due to the increasing consumption in human body to counteract the metabolic stress imposed by MetS, including hyperinsulinemia, hyperglycemia and dyslipidemia. The gene discussed is GDF2; the disease is metabolic syndrome.